高级检索
当前位置: 首页 > 详情页

Effect and Safety Study of Atorvastatin to Treat Chronic Subdural Hematoma

| 认领 | |

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究参与人:
研究单位: [1]Oriental Neurosurgery Evidence-Based-Study Team [2]Tongji hospital Wuhan, China [3]Prince of Wales Hospital Xianggang, China [4]Tangdu hospital Xian, China [5]Xijing Hospital Xian, China [6]The Affiliated Hospital of Xuzhou Medical College Xuzhou, China [7]General Hospital of Ningxia Medical University Yinchuan, China [8]The First Affiliated Hospital of Zhengzhou University Zhengzhou, China [9]The first hospital of Shanxi medical university Taiyuan, China [10]The second hospital of Hebei medical university Shijiazhuang, China [11]Huashan hospital Shanghai, China [12]Changzheng Hospital Shanghai, China [13]Ordos Central Hospital Ordos, China [14]Jiangsu province hospital Nanjing, China [15]Linyi People's Hospital Linyi, China [16]Inner mongolia people's hospital Hohehot, China [17]Qilu hospital of shandong university Jinan, China [18]Anhui provincial hospital Hefei, China [19]The second Affiliated hospital of zhejiang university school of medicine Hangzhou, China [20]117 Hospital of People's Liberation Army Hangzhou, China [21]Hainan general hospital Haikou, China [22]First Affiliated Hospital of Harbin Medical University Haerbing, China

关键词: chronic subdural hematoma Atorvastatin oral administration therapy

研究目的:
To evaluate the clinic effects and security of oral administration of Atorvastatin on chronic subdural hematoma (CSDH).

资源点击量:622 今日访问量:0 总访问量:452 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)